COVAX signs deal for 550 million Chinese Covid-19 vaccines amid questions over efficacy
CNN
COVAX has signed agreements with two Chinese pharmaceutical companies to buy more than half a billion of their Covid-19 vaccines by the first half of next year, Global Alliance for Vaccines and Immunization (Gavi) announced Monday.
Under the agreements, Chinese vaccine makers Sinopharm and Sinovac will begin to make 110 million doses immediately available, according to a news release from Gavi, a public-private global health partnership that is co-leading COVAX, a worldwide initiative aimed at distributing vaccines to countries regardless of wealth. The agreements came at a time when "the Delta variant is posing a rising risk to health systems," Gavi said in the statement.More Related News